On May 9, 2023 Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, reported it will participate in a fireside chat at the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day in New York City on Monday, May 15, 2023 (Press release, Nusano, MAY 9, 2023, View Source [SID1234631284]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

WHAT: Guggenheim Securities Fireside Chat
WHO: Chris Lowe, CEO, Nusano
Howard Lewin, COO and Co-Founder, Nusano
WHEN:
May 15, 2023
3:55 – 4:20 p.m. EST
WHERE: New York, NY

Lowe and Lewin will discuss how Nusano’s proprietary ion source and production platform are poised to supply desperately needed medical radioisotopes to support patient care and accelerate cancer therapeutics.